Pharmaceutical company Moderna has launched a large-scale Phase III trial that will test out a vaccine against norovirus, a frequent and sometimes dangerous source of food poisoning. Moderna’s ...

Be it from tap water on a vacation, some dodgy chicken, or something the kids have brought home from school, we've almost all ...

BRITS are being urged to stay at home and mask up when venturing outside after a “worrying” surge in norovirus cases. While ...

Volunteers in north Wales are among 25,000 people taking part in a global trial to find a vaccine against the symptoms of the ...

There are currently three vaccine candidates moving through the clinical pipeline in human trials right now, and the furthest along is Moderna, which has developed a norovirus vaccine with the ...

Norovirus cases are significantly increasing in the US and Canada. Moderna is developing an mRNA-based vaccine, currently in Phase 3 clinical trials, with the potential to be the first approved ...

HOSPITALS have been hit by a “highly infectious” winter vomiting bug which experts have warned you can catch more than once. Norovirus cases are continuing to soar with new NHS data ...

Norovirus, also known as the winter vomiting bug, is currently seeing a surge in infections with rates twice as high as previous years. In Wales cases of the virus were up 12% this winter compared ...

Moderna’s mRNA-1403 is a messenger RNA-based trivalent vaccine candidate designed to protect against multiple norovirus genotypes. Moderna provided an update on the status of its trial ...

The American pharmaceutical company Moderna is developing an mRNA-based vaccine candidate for norovirus, designated as mRNA-1403. This vaccine is designed to protect against multiple norovirus ...

Moderna (NASDAQ: MRNA) shares about 3% ahead of Wednesday market open after Goldman Sachs (NYSE: GS) cut its rating on the ...